143 related articles for article (PubMed ID: 38891885)
21. Modulation of the Anti-Tumor Efficacy of Photodynamic Therapy by Nitric Oxide.
Girotti AW
Cancers (Basel); 2016 Oct; 8(10):. PubMed ID: 27775600
[TBL] [Abstract][Full Text] [Related]
22. Bystander Effects of Nitric Oxide in Cellular Models of Anti-Tumor Photodynamic Therapy.
Bazak J; Korytowski W; Girotti AW
Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31661869
[TBL] [Abstract][Full Text] [Related]
23. Cytoprotective role of nitric oxide in HepG2 cell apoptosis induced by hypocrellin B photodynamic treatment.
Ji YY; Ma YJ; Wang JW
J Photochem Photobiol B; 2016 Oct; 163():366-73. PubMed ID: 27619738
[TBL] [Abstract][Full Text] [Related]
24. Antagonistic Effects of Endogenous Nitric Oxide in a Glioblastoma Photodynamic Therapy Model.
Fahey JM; Emmer JV; Korytowski W; Hogg N; Girotti AW
Photochem Photobiol; 2016 Nov; 92(6):842-853. PubMed ID: 27608331
[TBL] [Abstract][Full Text] [Related]
25. Cytoprotective signaling associated with nitric oxide upregulation in tumor cells subjected to photodynamic therapy-like oxidative stress.
Bhowmick R; Girotti AW
Free Radic Biol Med; 2013 Apr; 57():39-48. PubMed ID: 23261943
[TBL] [Abstract][Full Text] [Related]
26. Dual roles of nitric oxide in the regulation of tumor cell response and resistance to photodynamic therapy.
Rapozzi V; Della Pietra E; Bonavida B
Redox Biol; 2015 Dec; 6():311-317. PubMed ID: 26319434
[TBL] [Abstract][Full Text] [Related]
27. Bystander effect in photosensitized prostate cancer cells with a different grade of malignancy: The role of nitric oxide.
Gani M; Xodo LE; Rapozzi V
Nitric Oxide; 2022 Nov; 128():25-36. PubMed ID: 35970264
[TBL] [Abstract][Full Text] [Related]
28. Negative effects of tumor cell nitric oxide on anti-glioblastoma photodynamic therapy.
Girotti AW; Fahey JM; Korytowski W
J Cancer Metastasis Treat; 2020; 6():. PubMed ID: 33564720
[TBL] [Abstract][Full Text] [Related]
29. Bystander effects of nitric oxide in anti-tumor photodynamic therapy.
Bazak J; Fahey JM; Wawak K; Korytowski W; Girotti AW
Cancer Cell Microenviron; 2017; 4(1):. PubMed ID: 29201944
[TBL] [Abstract][Full Text] [Related]
30. Rapid upregulation of cytoprotective nitric oxide in breast tumor cells subjected to a photodynamic therapy-like oxidative challenge.
Bhowmick R; Girotti AW
Photochem Photobiol; 2011; 87(2):378-86. PubMed ID: 21143607
[TBL] [Abstract][Full Text] [Related]
31. Meta-tetrahydroxyphenyl chlorine mediated photodynamic therapy inhibits the migration and invasion of a nasopharyngeal carcinoma KJ-1 cell line.
Wang CP; Lou PJ; Lo FY; Shieh MJ
J Formos Med Assoc; 2014 Mar; 113(3):173-8. PubMed ID: 24630035
[TBL] [Abstract][Full Text] [Related]
32. Nitric oxide-elicited resistance to anti-glioblastoma photodynamic therapy.
Girotti AW; Fahey JM; Korytowski W
Cancer Drug Resist; 2020 3rd Quarter; 3(3):401-414. PubMed ID: 33073206
[TBL] [Abstract][Full Text] [Related]
33. Dihydroartemisinin prompts amplification of photodynamic therapy-induced reactive oxygen species to exhaust Na/H exchanger 1-mediated glioma cells invasion and migration.
Hou K; Liu J; Du J; Mi S; Ma S; Ba Y; Ji H; Li B; Hu S
J Photochem Photobiol B; 2021 Jun; 219():112192. PubMed ID: 34000476
[TBL] [Abstract][Full Text] [Related]
34. The role of nitric oxide in the treatment of tumours with aminolaevulinic acid-induced photodynamic therapy.
Reeves KJ; Reed MW; Brown NJ
J Photochem Photobiol B; 2010 Dec; 101(3):224-32. PubMed ID: 20724176
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.
Granados-Principal S; Liu Y; Guevara ML; Blanco E; Choi DS; Qian W; Patel T; Rodriguez AA; Cusimano J; Weiss HL; Zhao H; Landis MD; Dave B; Gross SS; Chang JC
Breast Cancer Res; 2015 Feb; 17(1):25. PubMed ID: 25849745
[TBL] [Abstract][Full Text] [Related]
36. A photodynamic bifunctional conjugate for prostate cancer: an in vitro mechanistic study.
Rapozzi V; Varchi G; Della Pietra E; Ferroni C; Xodo LE
Invest New Drugs; 2017 Feb; 35(1):115-123. PubMed ID: 27726093
[TBL] [Abstract][Full Text] [Related]
37. Cytoprotective induction of nitric oxide synthase in a cellular model of 5-aminolevulinic acid-based photodynamic therapy.
Bhowmick R; Girotti AW
Free Radic Biol Med; 2010 May; 48(10):1296-301. PubMed ID: 20138143
[TBL] [Abstract][Full Text] [Related]
38. Involvement of nitric oxide during phthalocyanine (Pc4) photodynamic therapy-mediated apoptosis.
Gupta S; Ahmad N; Mukhtar H
Cancer Res; 1998 May; 58(9):1785-8. PubMed ID: 9581812
[TBL] [Abstract][Full Text] [Related]
39. Reduced photoreceptor damage after photodynamic therapy through blockade of nitric oxide synthase in a model of choroidal neovascularization.
She H; Nakazawa T; Matsubara A; Hisatomi T; Young TA; Michaud N; Connolly E; Hafezi-Moghadam A; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2268-77. PubMed ID: 17460290
[TBL] [Abstract][Full Text] [Related]
40. Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA).
Reddy KRK; Dasari C; Duscharla D; Supriya B; Ram NS; Surekha MV; Kumar JM; Ummanni R
Angiogenesis; 2018 Feb; 21(1):79-94. PubMed ID: 29150732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
